Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.

Some excipients are currently available for the formulation of pharmaceutical suspensions. The objective of this study is to develop cheap and effective starch-based excipient that can be used as an effective alternative for the formulation of pharmaceutical suspensions. Carboxymethylated Plectranth...

Full description

Bibliographic Details
Main Author: Yonas Brhane
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0228547
id doaj-6cd98150b8f04f5693ba1975f74b05e2
record_format Article
spelling doaj-6cd98150b8f04f5693ba1975f74b05e22021-03-03T21:37:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01153e022854710.1371/journal.pone.0228547Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.Yonas BrhaneSome excipients are currently available for the formulation of pharmaceutical suspensions. The objective of this study is to develop cheap and effective starch-based excipient that can be used as an effective alternative for the formulation of pharmaceutical suspensions. Carboxymethylated Plectranthus edulis, Vatke (P. edulis) [fam., Lamiaceae], starch was evaluated as a suspending agent in metronidazole benzoate suspensions in comparison with sodium carboxymethyl cellulose (NaCMC) at a concentration range of 1-4% (w/v). The resulting suspensions were evaluated for their sedimentation volume (%), degree of flocculation, rheology, redispersibility, and dissolution rate. Stability studies were performed for 3 months. The apparent viscosities of the formulations prepared with carboxymethylated P. edulis starch at reaction condition E (CMPS-E) was significantly lower than that of NaCMC (p < 0.05). The flowability of the suspensions, at all concentration levels of the suspending agents, were in the order of CMPS-E > NaCMC. AT 1% concentrations, carboxymethylated P. edulis starch (76 ± 1.5%) provided significantly higher (p < 0.05) sedimentation volume than NaCMC (40 ± 1.5%). At 3% and 4%, both gave comparable sedimentation volume (100%). Potassium dihydrogen phosphate (KH2PO4) employed as a flocculating agent significantly increased (p < 0.05) the sedimentation volume of the suspensions prepared with carboxymethylated P.edulis starch and NaCMC. The redispersibilities of CMPS-E were better than those of NaCMC. All suspensions showed a release of greater than 85% of drug within 1 h. The results of stability studies showed that all suspension formulations were stable. From the foregoing, it can be concluded that carboxymethylated P. edulis starch could be used as an alternative suspending agent.https://doi.org/10.1371/journal.pone.0228547
collection DOAJ
language English
format Article
sources DOAJ
author Yonas Brhane
spellingShingle Yonas Brhane
Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
PLoS ONE
author_facet Yonas Brhane
author_sort Yonas Brhane
title Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
title_short Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
title_full Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
title_fullStr Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
title_full_unstemmed Evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
title_sort evaluation of carboxymethylated plectranthus edulis starch as a suspending agent in metronidazole benzoate suspension formulations.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Some excipients are currently available for the formulation of pharmaceutical suspensions. The objective of this study is to develop cheap and effective starch-based excipient that can be used as an effective alternative for the formulation of pharmaceutical suspensions. Carboxymethylated Plectranthus edulis, Vatke (P. edulis) [fam., Lamiaceae], starch was evaluated as a suspending agent in metronidazole benzoate suspensions in comparison with sodium carboxymethyl cellulose (NaCMC) at a concentration range of 1-4% (w/v). The resulting suspensions were evaluated for their sedimentation volume (%), degree of flocculation, rheology, redispersibility, and dissolution rate. Stability studies were performed for 3 months. The apparent viscosities of the formulations prepared with carboxymethylated P. edulis starch at reaction condition E (CMPS-E) was significantly lower than that of NaCMC (p < 0.05). The flowability of the suspensions, at all concentration levels of the suspending agents, were in the order of CMPS-E > NaCMC. AT 1% concentrations, carboxymethylated P. edulis starch (76 ± 1.5%) provided significantly higher (p < 0.05) sedimentation volume than NaCMC (40 ± 1.5%). At 3% and 4%, both gave comparable sedimentation volume (100%). Potassium dihydrogen phosphate (KH2PO4) employed as a flocculating agent significantly increased (p < 0.05) the sedimentation volume of the suspensions prepared with carboxymethylated P.edulis starch and NaCMC. The redispersibilities of CMPS-E were better than those of NaCMC. All suspensions showed a release of greater than 85% of drug within 1 h. The results of stability studies showed that all suspension formulations were stable. From the foregoing, it can be concluded that carboxymethylated P. edulis starch could be used as an alternative suspending agent.
url https://doi.org/10.1371/journal.pone.0228547
work_keys_str_mv AT yonasbrhane evaluationofcarboxymethylatedplectranthusedulisstarchasasuspendingagentinmetronidazolebenzoatesuspensionformulations
_version_ 1724232574317887488